跳至主要内容
临床试验/NCT00444652
NCT00444652Unknown4 期

Thromboprophylaxis During Bariatric Surgery

University Hospital, Strasbourg, France10 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2006年11月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
发起方
入组人数
300
试验地点
10
主要终点
Anti-Xa activity level measured 4 hours before and after enoxaparin injection at different doses

研究概览

简要总结

This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types of bariatric surgery.

- gastric banding and gastric bypass on anti-Xa activity levels

The study includes two groups of 150 patients scheduled for gastric banding or gastric bypass.

Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order to determine the best prophylactic regimen allowing expected values ranged between 0.3 and 0.5 IU / ml.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • BMI over 40
  • Gastric banding or gastric bypass

排除标准

  • Renal insufficiency
  • Thrombopenia
  • Long term anticoagulant treatment
  • Pregnancy
  • Allergy to heparin

结局指标

主要结局

Anti-Xa activity level measured 4 hours before and after enoxaparin injection at different doses

时间窗: 48 heures

次要结局

  • Microparticles(day 0, 1, 9,30)
  • Thrombotic events until D30(day 30)
  • Bleeding events(day 30)

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Thromboprophylaxis and Bariatric Surgery | 临床试验